IP Verse

Galenicum Health Sl competitive analysis

Latest publications and patents of Galenicum Health Sl New

Explore the latest publications and patents granted to Galenicum Health Sl, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Galenicum Health Sl

EP3512505
Mar 15, 2023Vildagliptin Pharmaceutical CompositionsGranted And Under Opposition
EP3240529
Feb 2, 2022Stable Pharmaceutical Compositions Comprising MicafunginGranted And Under Opposition
EP2915526
Jun 2, 2021Pharmaceutical Compositions Comprising AnagrelideGranted And Under Opposition
EP3102187
Mar 25, 2020Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release TabletsRevoked

Latest oppositions filed by Galenicum Health Sl

Explore patent oppositions filed by Galenicum Health Sl against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3090730
Novel Pharmaceutical CompositionNOVARTISJan 9, 2025
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024
EP3270909
Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular RiskESPERION THERAPEUTICSJul 31, 2024
EP3634463
Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALSJun 27, 2024
EP3810201
Gip/Glp1 Agonist CompositionsELI LILLYMar 7, 2024
EP2508188
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateASTRAZENECAFeb 9, 2024
EP3191461
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022
EP2863895
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 14, 2022
EP3431475
Solid Forms Of A Selective Cdk4/6 InhibitorPFIZERJan 7, 2022
EP2797581
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEFeb 8, 2021

Latest patents of Galenicum Health Sl opposed by its competitors

Explore Galenicum Health Sl's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3512505
Mar 15, 2023Vildagliptin Pharmaceutical Compositions2
EP3240529
Feb 2, 2022Stable Pharmaceutical Compositions Comprising Micafungin2
EP2915526
Jun 2, 2021Pharmaceutical Compositions Comprising Anagrelide1
EP3102187
Mar 25, 2020Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets7

Latest PTAB cases involving Galenicum Health Sl

Discover the latest PTAB cases involving Galenicum Health Sl, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Galenicum Health Sl with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
GALENICUM HEALTH SL112 - - Defensive
DENTONS PATENT SOLUTIONS1 - - - Highly Aggressive
DENTONS UK AND MIDDLE EAST2 - - - Highly Aggressive
ELKINGTON AND FIFE85 - - - Highly Aggressive